Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 96 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Vassiliki Kotoula  [Clear All Filters]
Journal Article
Koletsa, T., Kotoula V., Karayannopoulou G., Nenopoulou E., Karkavelas G., Papadimitriou C. S., et al. (2010).  EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.. Histol Histopathol. 25(9), 1171-9.
Kotoula, V., Karavasilis V., Zagouri F., Kouvatseas G., Giannoulatou E., Gogas H., et al. (2016).  Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.. Breast Cancer Res Treat. 158(2), 307-21.
De Roock, W., Claes B., Bernasconi D., De Schutter J., Biesmans B., Fountzilas G., et al. (2010).  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.. Lancet Oncol. 11(8), 753-62.
Karavasilis, V., Kosmidis P., Syrigos K. N., Mavropoulou P., Dimopoulos M. A., Kotoula V., et al. (2014).  Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.. Anticancer Res. 34(10), 5649-55.
Fountzilas, E., Kotoula V., Zagouri F., Giannoulatou E., Kouvatseas G., Pentheroudakis G., et al. (2016).  Disease evolution and heterogeneity in bilateral breast cancer.. Am J Cancer Res. 6(11), 2611-2630.
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Athanasiou, E., Kaloutsi V., Kotoula V., Hytiroglou P., Kostopoulos I., Zervas C., et al. (2001).  Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.. Am J Clin Pathol. 116(4), 535-42.
Cohen, S. A., Yu M., Baker K., Redman M., Wu C., Heinzerling T. J., et al. (2017).  The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.. Clin Epigenetics. 9, 46.
Batistatou, A., Kotoula V., Bobos M., Kouvatseas G., Zagouri F., Tsolaki E., et al. (2018).  Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.. Clin Breast Cancer. 18(1), 53-62.e3.
Wang, Q., Kotoula V., Hsu P-C., Papadopoulou K., Ho J. W. K., Fountzilas G., et al. (2019).  Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.. BMC Med Genomics. 12(Suppl 9), 181.
Girtovitis, F., Papadopoulos A., Ntaios G., Kaloutsi V., Kotoula V., & Kaiafa G. (2009).  Coexistence of B-cell non-Hodgkin lymphoma and cutaneous T-cell lymphoma in a patient with chronic hepatitis C and cryoglobulinaemia.. Intern Med J. 39(8), 550-3.
Fotiadu, A., Gagalis A., Akriviadis E., Kotoula V., Sinakos E., Karkavelas G., et al. (2010).  Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease.. Pathol Int. 60(2), 87-92.
Katafigiotis, S., Papamichos S. I., Katopodi R., Papazisis K., Mylonaki E., Repana D., et al. (2011).  A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state.. Eur J Cancer Prev. 20(3), 248-51.
Pyrpasopoulou, A., Kotoula V., Cheva A., Hytiroglou P., Nikolakaki E., Magras I. N., et al. (2004).  Bone morphogenetic protein expression in newborn rat kidneys after prenatal exposure to radiofrequency radiation.. Bioelectromagnetics. 25(3), 216-27.
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Pentheroudakis, G., Kotoula V., Kouvatseas G., Charalambous E., Dionysopoulos D., Zagouri F., et al. (2014).  Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.. Clin Breast Cancer. 14(5), 330-8.
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
Lakis, S., Papamitsou T., Panagiotopoulou C., Kotakidou R., & Kotoula V. (2010).  AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.. World J Gastroenterol. 16(20), 2476-83.
Koletsa, T., Stavridi F., Bobos M., Kostopoulos I., Kotoula V., Eleftheraki A. G., et al. (2014).  alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.. BMC Clin Pathol. 14, 28.
Kotoula, V., Bobos M., Alexopoulou Z., Papadimitriou C., Papadopoulou K., Charalambous E., et al. (2014).  Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.. PLoS One. 9(8), e103707.
Bobos, M., Kotoula V., Kaloutsi V., Karayannopoulou G., Papadimitriou C. S., & Kostopoulos I. (2009).  Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.. Histol Histopathol. 24(8), 1035-48.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές